In addition, the results have shown that siRNA-mediated GILZ KD stimulates the G1-to-G0 phase transition, thereby repressing the formation of tumour-like spheres in vitro and delaying tumour development in vivo. This evidence concerns the gene TSC22D3 and neoplasm.